Patents for C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621) |
---|
03/27/2003 | WO2003024942A1 Thiazolidine derivative and medicinal use thereof |
03/27/2003 | WO2003024933A1 2-phenyl-3-heteroarylpropionic acid derivative or salt thereof and medicine containing the same |
03/27/2003 | WO2003024923A1 Sulfonamide compounds as protease inhibitors |
03/27/2003 | WO2003024922A1 Hydroxyfattysulfonic acid analogs |
03/27/2003 | WO2003024529A1 Simplified sarcodictyn derivatives as anti-tumor agents |
03/27/2003 | WO2003024448A2 Inhibitors of histone deacetylase |
03/27/2003 | WO2003024441A1 Novel use of tricyclic compound |
03/27/2003 | WO2003024395A2 Linked biaryl compounds |
03/27/2003 | WO2003024390A2 Hydroxyeicosenoic acid analogs |
03/27/2003 | WO2002028844A1 Thiazole or oxazole derivatives |
03/27/2003 | WO2002014261A3 4-substituted d-glutamic acid derivatives for use as antibiotic |
03/27/2003 | US20030060625 Para-amine substituted phenylamide glucokinase activators |
03/27/2003 | US20030060623 Having microtubule-stabilizing effects and cytotoxic activity against rapidly proliferating cells, such as, tunior cells or other hyperproliferative cellular disease |
03/27/2003 | US20030060492 Nitrosated and nitrosylated H2 receptor antagonist compounds, compositions and methods of use |
03/27/2003 | US20030060461 Cyclic diamine compound with condensed-ring groups |
03/27/2003 | US20030060456 Such as 4-(2,3-dihydro-1-benzothien-5-yloxy)-3-((methylamino) methyl)-benzenesulfonamide for use as serotonin re-uptake inhibitors (SSRIs) in treatment of depression, attention deficit hyperactivity disorder, obsessive-compulsive disorder |
03/27/2003 | US20030060419 Used to treat stroke, cerebral ischemia, pain, head trauma, asthma, amyotropic lateral sclerosis, or epilepsy |
03/27/2003 | CA2465978A1 Inhibitors of histone deacetylase |
03/27/2003 | CA2460512A1 Thiazolidine derivatives and medicinal use thereof |
03/27/2003 | CA2460358A1 Hydroxyfattysulfonic acid analogs |
03/27/2003 | CA2460263A1 Hydroxyeicosenoic acid analogs |
03/27/2003 | CA2460244A1 Simplified sarcodictyn derivatives as anti-tumor agents |
03/27/2003 | CA2460151A1 Cytokine receptor |
03/27/2003 | CA2460150A1 Aryl derivatives for the treatment of diabetes, hyperlipidemia, hypercholesterolemia and atherosclerosis |
03/27/2003 | CA2460149A1 2-phenyl-3-heteroarylpropionic acid derivative or salt thereof and medicine containing the same |
03/27/2003 | CA2423885A1 Thiazole and oxazole derivatives |
03/26/2003 | EP1295878A1 Novel pyrazinone derivatives |
03/26/2003 | EP1295875A1 Heterocyclic compounds |
03/26/2003 | EP1295872A1 Drug composition antagonistic to both pgd 2?/txa 2? receptors |
03/26/2003 | EP1295868A1 Amide compounds and use thereof |
03/26/2003 | EP1294823A1 Double-spiro organic compounds and electroluminescent devices |
03/26/2003 | EP1294704A1 Aryl phenylheterocyclyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents |
03/26/2003 | EP1294691A1 Serine protease inhibitors |
03/26/2003 | EP1294677A1 Benzophenones and sulfones as inhibitors of glycine uptake |
03/26/2003 | EP1294366A1 Pharmaceutical compounds for treating copd |
03/26/2003 | EP1095930B1 Novel compounds |
03/26/2003 | EP1025085B1 Heterocycles useful in the treatment of benign prostatic hyperplasia and intermediates thereof |
03/26/2003 | EP0801640B1 2,5-diamino-3,4-disubstituted-1,6-diphenylhexane isosteres comprising benzamide, sulfonamide and anthranilamide subunits and methods of using same |
03/26/2003 | EP0783496B1 Thiazolidinedione derivatives, their production and use |
03/26/2003 | EP0606248B1 Heteroaryl amines as novel acetyl cholinesterase inhibitors |
03/26/2003 | CN1406234A 8,8A-dihydro-indeno [1,2-D] thiazole derivatives with a sulphonamido or sulphono substituent in the 2 position, a method for production thereof and use thereof as a medicament |
03/26/2003 | CN1103775C Vitronectin receptor antagonists, their preparation and use |
03/26/2003 | CN1103590C Use of thiazolidinediones to prevent or delay on set of NIDDM |
03/25/2003 | US6538013 Acyclic and cyclic guanidine-and acetamidine derivatives, their preparation and their use as pesticides, esp. as parasiticides |
03/25/2003 | US6537712 Dry development systems |
03/20/2003 | WO2003022801A1 Reverse hydroxamic acid derivatives |
03/20/2003 | WO2002100845A8 Hv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis |
03/20/2003 | WO2002094768A3 Aza hydroxylated ethyl amine compounds |
03/20/2003 | WO2002067865A3 N-(aryl)-2-arylethenesulfonamides and therapeutic uses thereof |
03/20/2003 | WO2002040431B1 Compounds having fungicidal activity and processes to make and use same |
03/20/2003 | US20030055287 Phthalic acid diamide derivatives, fluorine-containing aniline compounds as starting material, agricultural and horticultural insecticides, and a method for application of the insecticides |
03/20/2003 | US20030055263 Carboxylic acid derivatives, medicaments comprising these compounds, their use and processes for their production |
03/20/2003 | US20030055247 Thiazolyl(pyridyl)ethyne compounds |
03/20/2003 | US20030055246 Serine protease inhibitors |
03/20/2003 | US20030055229 Chemical intermediates, useful for the preparation of insecticides |
03/20/2003 | US20030055100 Cytotoxic compounds |
03/20/2003 | US20030055093 For therapy of cardiovascular diseases, stable or unstable angina pectoris, coronary heart disease, stable or unstable angina pectoris, coronary heart disease, Prinzmetal angina, acute coronary syndrome, heart failure, myocardial infarction |
03/20/2003 | US20030055079 For therapy and prophylaxis of metabolic disorders related to insulin resistance or hyperglycemia typically associated with obesity or glucose intolerance |
03/20/2003 | US20030055064 Piperazine compounds and medicinal use thereof |
03/20/2003 | US20030055038 For therapy of central nervous system and other disorders |
03/20/2003 | US20030055025 For therapy of bacterial infections and neoplasms, |
03/20/2003 | US20030054974 Non-oxidatively metabolized compounds and compositions, synthetic pathways therefor, and uses thereof |
03/20/2003 | US20030052310 Perfluorinated amide salts and their uses as ionic conducting materials |
03/19/2003 | EP1293207A1 Use of ritonavir (ABT-538) for improving the pharmacokinetics of drugs metabolized by cytochrome P450 in a method of treating aids |
03/19/2003 | EP1292578A1 Para-aminophenol derivatives and their use as developers for producing oxidation colorations |
03/19/2003 | EP1292573A2 Substituted thioacetamides |
03/19/2003 | EP1292308A1 Alpha,beta-unsaturated sulfones for treating proliferative disorders |
03/19/2003 | EP1292300A1 Combinations od dipeptidyl peptidase iv inhibitors and other antidiabetic agents for the treatment fo diabete mellitus |
03/19/2003 | EP1114047B1 An improved process for the preparation of thiazolidine-2,4-dione derivatives |
03/19/2003 | EP0768879B1 Thiadiazole compounds as d3 dopamine receptor ligands |
03/19/2003 | CN1404477A 哌嗪和哌啶衍生物 Piperazine and piperidine derivatives |
03/19/2003 | CN1404473A Substituted 8,8a-dihydro-3aH-indeno [1,2-D] thiazoles, a method for their production and their use as medicaments |
03/19/2003 | CN1404468A Novel use of phenylheteroalkylamine derivatives |
03/19/2003 | CN1403447A Synthesis of 1,3-terahydro thiazolone compound |
03/18/2003 | US6534659 Sufidomaidocarboxylic acids, method for production thereof, and use therefor |
03/18/2003 | US6534532 Carbanilides as pesticides |
03/18/2003 | US6534529 Synergistic insecticide mixtures |
03/18/2003 | US6534493 α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors |
03/18/2003 | US6534201 Organometallic luminescent materials and organic electroluminescent device containing same |
03/18/2003 | CA2223722C Keratin fibre oxidation dye composition and dye process using the composition |
03/13/2003 | WO2003021228A2 Heteroaryl substituted benzothiazole dioxetanes |
03/13/2003 | WO2003020705A1 Urea and thiourea derivatives as non-nucleoside reverse transcriptase inhibitors |
03/13/2003 | WO2003020694A1 Derivatives of c2-substituted indan-1-ol systems, methods for the production thereof and their use as medicaments |
03/13/2003 | WO2002096901A3 1,3-dihydroxybenzene derivatives and colorants containing said compounds |
03/13/2003 | WO2002078625A3 Therapeutic combinations for cardiovascular and inflammatory indications |
03/13/2003 | WO2002072543A3 Rxr activating molecules |
03/13/2003 | US20030050311 A novel phenyl oxazoles, thiazoles, oxazolines, oxadiazoles or benzoxazoles for treating neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease, amytrophic lateral sclerosis or cerebral trauma |
03/13/2003 | US20030050301 A drug mixture additionally comprising an antihypertensive agent or it's prodrug and a carrier, vehicle or diluent |
03/13/2003 | CA2459918A1 Heteroaryl substituted benzothiazole dioxetanes |
03/13/2003 | CA2458521A1 Derivatives of c2-substituted indan-1-ol systems, methods for the production thereof and their use as medicaments |
03/13/2003 | CA2458093A1 Urea and thiourea derivatives as non-nucleoside reverse transcriptase inhibitors |
03/12/2003 | EP1291345A1 Diacid-substituted heteroaryl derivatives as matrix metalloproteinase inhibitors |
03/12/2003 | EP1289980A1 Bicyclyl or heterobicyclylmethanesulfonylamino-substituted n-hydroxyformamides |
03/12/2003 | EP1289972A1 Serine protease inhibitors |
03/12/2003 | EP1289971A1 Benzamide derivatives and their use as apob-100 and mtp inhibitors |
03/12/2003 | EP1289958A2 BENZOPHENONES AS INHIBITORS OF IL-1$g(b) AND TNF-$g(a) |
03/12/2003 | EP1036058B1 Adamantane derivatives |
03/12/2003 | EP0900198B1 New vitamin d derivatives with carbo- or heterocyclic substituents at c-25, a process for their production, intermediate products and their use for producing medicaments |
03/12/2003 | EP0874830B1 A metalloproteinase inhibitor, a pharmaceutical composition containing it and the pharmaceutical use and method useful for the preparation thereof |
03/12/2003 | EP0873325B1 Process for producing guanidine derivatives, intermediates therefor and their production |